TLDR Stifel lifts Applied Materials price target from $250 to $340 with Buy rating intact RBC Capital starts coverage with Outperform rating and $385 target priceTLDR Stifel lifts Applied Materials price target from $250 to $340 with Buy rating intact RBC Capital starts coverage with Outperform rating and $385 target price

Applied Materials (AMAT) Stock: Wall Street Upgrades Signal Confidence in Chip Equipment Leader

3 min read

TLDR

  • Stifel lifts Applied Materials price target from $250 to $340 with Buy rating intact
  • RBC Capital starts coverage with Outperform rating and $385 target price
  • Stock trades at 20% discount to semiconductor equipment peers at 30x P/E
  • Company marks eighth straight year of dividend growth with $0.46 quarterly payout
  • Analysts highlight strong DRAM positioning and broad technology portfolio as catalysts

Applied Materials received back-to-back analyst upgrades this week as Wall Street grows more optimistic about the semiconductor equipment maker’s prospects.


AMAT Stock Card
Applied Materials, Inc., AMAT

Stifel bumped its price target to $340 from $250. RBC Capital launched coverage with an Outperform rating and $385 target. The stock currently changes hands around $302.

Both firms cite Applied Materials’ market positioning as a key reason for their bullish stance. The company’s diverse product lineup gives it multiple paths to growth that competitors lack.

Stifel pointed to Applied Materials’ ability to solve complex technology challenges for chip manufacturers. The firm believes this capability will drive market share gains as the industry enters its next growth phase.

RBC Capital analyst Srini Pajjuri focused on the DRAM opportunity. He expects spending on DRAM manufacturing equipment to grow faster than the overall wafer fab equipment market over the coming year.

The stock delivered a 77% return over the past 12 months. This came despite headwinds from China restrictions and softer spending on older chip technology nodes.

Valuation Gap Creates Entry Point

Applied Materials trades at 30 times earnings. That represents a 20% discount compared to other semiconductor capital equipment companies.

RBC Capital views this valuation gap as an opportunity. The firm sees a favorable risk-reward setup at current levels.

Stifel expects Applied Materials to hit higher revenue and profit peaks during the next industry upswing. The company showed resilience during the recent downturn, which strengthens the case for premium valuation.

Applied Materials continues rewarding shareholders through dividends. The company just announced its eighth consecutive annual dividend increase to $0.46 per share quarterly.

Technology Transitions Drive Growth

Several technology shifts should benefit Applied Materials in coming years. The move to backside power delivery represents one major opportunity.

Hybrid bonding technology is another growth area. Advanced 3D transistor designs also require new equipment capabilities.

Applied Materials’ broad product portfolio positions it to capture spending across these emerging technologies. Limited merger activity in the sector makes this internal capability even more valuable.

TD Cowen previously set a $315 target on the stock. KeyBanc Capital Markets established a $285 target. UBS upgraded the stock to Buy with a $285 target based on equipment demand expectations.

The stock trades near its 52-week high of $310.64. Analyst targets span from $190 to $425, reflecting varied views on upside potential.

Applied Materials holds strategic positions in high-growth chip manufacturing segments. DRAM memory and leading-edge foundry production remain key focus areas.

Wafer fab spending should increase over the next year. Analysts expect Applied Materials to grow at least in line with the broader market during this period.

The company faced share losses in certain categories last year. China-related pressures and competitive dynamics contributed to these challenges.

Despite near-term obstacles, analysts see multiple catalysts ahead. The combination of technology transitions, attractive valuation, and market position drives the positive outlook.

RBC Capital noted Applied Materials beat the SOX semiconductor index last year but trailed some domestic equipment peers. The firm expects this performance gap to narrow as industry conditions improve.

The post Applied Materials (AMAT) Stock: Wall Street Upgrades Signal Confidence in Chip Equipment Leader appeared first on Blockonomi.

Market Opportunity
PoP Planet Logo
PoP Planet Price(P)
$0.01149
$0.01149$0.01149
-0.08%
USD
PoP Planet (P) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29